Loading...

Interim treatment: Bridging delays to opioid treatment access

OBJECTIVE: Despite the undisputed effectiveness of agonist maintenance for opioid dependence, individuals can remain on waitlists for months, during which they are at significant risk for morbidity and mortality. To mitigate these risks, the Food and Drug Administration in 1993 approved interim trea...

Full description

Saved in:
Bibliographic Details
Published in:Prev Med
Main Author: Sigmon, Stacey C.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592374/
https://ncbi.nlm.nih.gov/pubmed/25937593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ypmed.2015.04.017
Tags: Add Tag
No Tags, Be the first to tag this record!